N-terminal pro-brain natriuretic peptide predicts myocardial ischemia and is related to postischemic left-ventricular dysfunction in patients with stable coronary artery disease

Journal of Nuclear Cardiology

Volumn 14, Issue 6, 2007, Pages 835-842

  Vanzetto, Gerald ^a   Jacon, Peggy ^a   Calizzano, Alex ^a   Neuder, Yannick ^a   Faure, Patrice ^a   Fagret, Daniel ^a   Machecourt, Jacques ^a  

^a GRENOBLE UNIVERSITY HOSPITAL   (France)

Author keywords

ejection fraction; exercise stress test; myocardial ischemia; myocardial perfusion imaging; Natriuretic peptide

Indexed keywords

ACETYLSALICYLIC ACID; AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CLOPIDOGREL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; THALLIUM 201;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; CORONARY ARTERY DISEASE; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; EXERCISE TEST; FEMALE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE FAILURE; HEART MUSCLE ISCHEMIA; HEART MUSCLE PERFUSION; HIGH RISK PATIENT; HUMAN; MAJOR CLINICAL STUDY; MALE; PREDICTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; REST; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; STATISTICAL SIGNIFICANCE; TRANSLUMINAL CORONARY ANGIOPLASTY;

ADULT; BIOLOGICAL MARKERS; CORONARY ARTERY DISEASE; FEMALE; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL ISCHEMIA; NATRIURETIC PEPTIDE, BRAIN; PEPTIDE FRAGMENTS; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; VENTRICULAR DYSFUNCTION, LEFT;

EID: 36049029002     PISSN: 10713581     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.nuclcard.2007.07.011     Document Type: Article

References (26)

1. McDonagh T.A., Robb S.D., Murdoch D.R., Morton J.J., Ford I., Morrison C.E., et al. Biochemical detection of left-ventricular systolic dysfunction. Lancet 351 (1998) 9-13
2. Tsutamoto T., Wada A., Maeda K., Hisanaga T., Maeda Y., Fukai D., et al. Attenuation of compensation of endogenous cardiac natriuretic peptide system in chronic heart failure: prognostic role of plasma brain natriuretic peptide concentration in patients with chronic symptomatic left ventricular dysfunction. Circulation 96 (1997) 509-516
3. Arakawa N., Nakamura M., Aoki H., and Hiramori K. Relationship between plasma level of brain natriuretic peptide and myocardial infarct size. Cardiology 85 (1994) 334-340
4. Omland T., Aakvaag A., and Vik-Mo H. Plasma cardiac natriuretic peptide determination as a screen test for the detection of patients with mild left ventricular impairment. Heart 76 (1996) 232-237
5. Darbar D., Davidson N.C., Gillespie N., Choy A.M., Lang C.C., Shyr Y., et al. Diagnostic value of B-type natriuretic peptide concentrations in patients with acute myocardial infarction. Am J Cardiol 78 (1996) 284-287
6. Marumoto K., Hamada M., and Hiwada K. Increased secretion of atrial and brain natriuretic peptides during acute myocardial ischemia induced by dynamic exercise in patients with angina pectoris. Clin Sci 88 (1995) 551-556
7. Bibbins-Domingo K., Ansari M., Schiller N.B., Massie B., and Whooley M.A. B-type natriuretic peptide and ischemia in patients with stable coronary disease: data from the Heart and Soul Study. Circulation 108 (2003) 2987-2992
8. Asada J., Tsuji H., Iwasaka T., Thomas J.D., and Lauer M.S. Usefulness of plasma brain natriuretic peptide levels in predicting dobutamine-induced myocardial ischemia. Am J Cardiol 93 (2004) 702-704
9. Palumbo B., Siepi D., Lupattelli G., Sinzinger H., Fiorucci G., Anniboletti P.F., et al. Usefulness of brain natriuretic peptide levels to discriminate patients with stable angina pectoris without and with electrographic myocardial ischemia and patients with healed myocardial infarction. Am J Cardiol 94 (2004) 780-783
10. Marie P.Y., Mertes P.M., Hassan-Sebbag N., de Talence N., Djaballah K., Djaballah W., et al. Exercise release of cardiac natriuretic peptides is markedly enhanced when patients with coronary artery disease are treated medically by beta-blockers. J Am Coll Cardiol 43 (2004) 353-359
11. Foote R.S., Pearlman J.D., Siegel A.H., and Yeo K.T. Detection of exercise-induced ischemia by changes in B-type natriuretic peptides. J Am Coll Cardiol 44 (2004) 1980-1987
12. Win H.K., Chang S.M., Raizner M., Shah G., Al Basky F., Desai U., et al. Percent change in B-type natriuretic peptide levels during treadmill exercise as a screening test for exercise induced myocardial ischemia. Am Heart J 150 (2005) 695-700
13. Staub D., Nusbaumer C., Zellweger M.J., Jonas N., Wild D., Pfisterer M.E., et al. Use of B-natriuretic peptide in the detection of myocardial ischemia. Am Heart J 151 (2006) 1223-1230
14. Sabatine M.S., Morrow D.A., de Lemos J.A., Omland T., Desai M.Y., Tanasijevic M., et al. Acute changes in circulating natriuretic peptide levels in relation to myocardial ischemia. J Am Coll Cardiol 44 (2004) 1988-1995
15. Omland T., Richards A.M., Wergeland R., and Vik-Mo H. B-type natriuretic peptide and long-term survival in patients stable coronary artery disease. Am J Cardiol 95 (2005) 24-28
16. Weber M., Dill T., Arnold R., Rau M., Ekinci O., Muller K.D., et al. N-terminal B-type natriuretic peptide predicts extent of coronary artery disease and ischemia in patients with stable angina pectoris. Am Heart J 148 (2004) 612-620
17. Underwood S.R., Anagnostopoulos C., Cerqueira M., Ell P.J., Flint E.J., Harbinson M., et al. Myocardial perfusion scintigraphy: the evidence. Eur J Nucl Med Mol Imag 31 (2004) 261-291
18. Vanzetto G., Ormezzano O., Fagret D., Comet M., Denis B., and Machecourt J. Long-term additive prognostic value of thallium-201 myocardial perfusion imaging over clinical and exercise stress test in low to intermediate risk patients: study in 1137 patients with 6-year follow-up. Circulation 100 (1999) 1521-1527
19. Berman S., Abidov A., Kang X., Hayes S.W., Friedman J.D., Sciammarella M.G., et al. Prognostic validation of a 17-segment score derived from a 20-segment score for myocardial perfusion SPECT interpretation. J Nucl Cardiol 11 (2004) 414-423
20. Wolber T., Maeder M., Weilenmann D., Duru F., Bluzaite I., Riesen W., et al. Integration of B-type natriuretic peptide levels with clinical data and exercise. Testing for predicting coronary artery disease. Am J Cardiol 98 (2006) 764-767
21. Zaid G., Tanchilevitch A., Rivlin E., Gropper R., Rosenschein U., Lanir A., et al. Diagnostic accuracy of serum B-type natriuretic peptide for myocardial ischemia detection during exercise testing with SPECT perfusion imaging. Int J Cardiol 117 (2007) 157-164
22. Conen D., Jander N., Trenk D., Neumann F.J., and Mueller C. The use of B-type natriuretic peptides in the detection of myocardial ischemia in settings with rapid access to coronary angiography. Int J Cardiol 119 (2007) 416-418
23. Sokoll L.J., Baum H., Collinson P.O., Gurr E., Haass M., Luthe H., et al. Multicenter analytical performance evaluation of the Elecsys proBNP assay. Clin Chem Lab Med 42 (2004) 965-972
24. Scharhag J., Urhausen A., Schneider G., Herrmann M., Schumacher K., Haschke M., et al. Reproducibility and clinical significance of exercise-induced increases in cardiac troponins and N-terminal pro brain natriuretic peptide in endurance athletes. Eur J Cardiovasc Prev Rehabil 13 (2006) 388-397
25. Gowda R.M., Khan I.A., Vasavada B.C., and Sacchi T.J. Reversible myocardial dysfunction: basics and evaluation. Int J Cardiol 97 (2004) 349-353
26. Rinaldi C.A., Masani N.D., Linka A.Z., and Hall R.J. Effect of repetitive episodes of exercise induced myocardial ischemia on left ventricular function in patients with chronic stable angina: evidence for cumulative stunning or ischaemic preconditioning?. Heart 81 (1999) 404-411